Article Details
Retrieved on: 2025-04-24 20:21:27
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses NurExone Biologic Inc.'s pioneering work with extracellular vesicles, specifically exosomes, for nerve regeneration therapies. Focused on stem cells and neuroregeneration, their exosome platform targets spinal cord injury and other central nervous system conditions.
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here